Latest News about LLY
Recent news which mentions LLY
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
Today 8:14 EDT
From Benzinga
A Short Delay Is Still Bad News for AbbVie
Today 8:02 EDT
From Motley Fool
From MarketWatch
With a New Diabetes Product Coming to Market, What Lies Ahead for Zealand Pharma Investors?
April 12, 2021
From Motley Fool
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
April 10, 2021
From Benzinga
From Motley Fool
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
April 09, 2021
From Benzinga
Provention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For Diabetes
April 09, 2021
From Benzinga
From MarketWatch
From Benzinga
Eli Lilly-Incyte's Baricitinib Study In Hospitalized COVID-19 Patients Fails To Meet Main Goal
April 08, 2021
From Benzinga
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
April 07, 2021
From Benzinga
Is Silicon Valley Replacing Big Pharma In Neuroscience?
April 06, 2021
From Benzinga
Better Buy for 2021: Pfizer or Gilead?
April 05, 2021
From Motley Fool
The Week Ahead In Biotech: Regeneron, Supernus FDA Decisions, Cancer Conference Presentations In The Spotlight
April 03, 2021
From Benzinga
Fortress Biotech's Partner Firm Expands Footprint In Dermatology With Qbrexza Acquisition
April 01, 2021
From Benzinga
From Motley Fool
The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings
March 30, 2021
From Benzinga
Why Humanigen Stock Is Skyrocketing Today
March 29, 2021
From Motley Fool
Eli Lilly-Vir Bamlanivimab-VIR-7831 Combo Reduces Viral Load By 70% In Low-Risk COVID-19 Patients
March 29, 2021
From Benzinga
This Stalwart's Growth Story Isn't Over Yet
March 29, 2021
From Motley Fool
2 Surefire Stocks to Buy for a Biden Bull Market
March 27, 2021
From Motley Fool
From Benzinga
5 Stocks To Watch For March 26, 2021
March 26, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.